Home ➤ Life Science ➤ Healthcare ➤ Near-Patient Molecular Solutions Market
Near-Patient Molecular Solutions Market
Published date: Oct 2025 • Formats:
Request Sample Schedule a Call

Near-Patient Molecular Solutions Market By Product Type (Infectious diseases testing kits, Urinalysis testing kits, Tumor/cancer markers, Pregnancy and fertility, Hematology testing kits, Glucose monitoring kits, Drugs-of-abuse testing kits, Coagulation monitoring kits, Cardiometabolic monitoring kits, and Others), By Technology (PCR-based, Microarray-based, Hybridization-based, and Genetic sequencing based), By End-user (Hospitals, Research Laboratories, Homecare, and Diagnostic Laboratories), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034

  • Published date: Oct 2025
  • Report ID: 162285
  • Number of Pages: 334
  • Format:
  • keyboard_arrow_up
    • 1. Executive Summary
      • 1.1. Definition
      • 1.2. Market Snapshot
      • 1.3. Market Overview
      • 1.4. Segment Overview
      • 1.5. Regional Overview
      • 1.6. Competitive Landscape
      • 1.7. Taxonomy
      • 1.8. Industry Voices
    • 2. Global Market Overview
      • 2.1. Global Market Insights and Industry Overview
      • 2.2. Market Dynamics
        • 2.2.1. Drivers
        • 2.2.2. Restraints
        • 2.2.3. Opportunities
        • 2.2.4. Key Near-Patient Molecular Solutions Market Trends
      • 2.3. Technology Landscape
      • 2.4. Regulatory Framework
      • 2.5. Sustainability and ESG (Environmental, Social, Governance)
      • 2.6. Opportunity Map Analysis
      • 2.7. Opportunity Orbits
      • 2.8. PESTLE Analysis
      • 2.9. PORTER’S Five Force Analysis
      • 2.10. Drivers & Restraints Impact Analysis
      • 2.11. Value Chain Analysis
        • 2.11.1. List of Raw Materials Suppliers
        • 2.11.2. List of Near-Patient Molecular Solutions Manufacturers
        • 2.11.3. List of Dealer/Distributors
      • 2.12. Regional Market Share and BPS Analysis
      • 2.13. Impact of Macro-economic Factors/Geopolitical Factors
    • 3. Global Near-Patient Molecular Solutions Market Analysis and Forecast, By Segment, 2020-2034
      • 3.1. Key Findings
      • 3.2. Global Near-Patient Molecular Solutions Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product Type, 2020-2034
      • 3.3. Global Near-Patient Molecular Solutions Market Attractiveness Analysis, By Product Type
        • 3.3.1. Infectious diseases testing kits
          • 3.3.1.1. Insights
          • 3.3.1.2. Key Takeaways
        • 3.3.2. Urinalysis testing kits
          • 3.3.2.1. Insights
          • 3.3.2.2. Key Takeaways
        • 3.3.3. Tumor/cancer markers
          • 3.3.3.1. Insights
          • 3.3.3.2. Key Takeaways
        • 3.3.4. Pregnancy and fertility
          • 3.3.4.1. Insights
          • 3.3.4.2. Key Takeaways
        • 3.3.5. Hematology testing kits
          • 3.3.5.1. Insights
          • 3.3.5.2. Key Takeaways
        • 3.3.6. Glucose monitoring kits
          • 3.3.6.1. Insights
          • 3.3.6.2. Key Takeaways
        • 3.3.7. Drugs-of-abuse testing kits
          • 3.3.7.1. Insights
          • 3.3.7.2. Key Takeaways
        • 3.3.8. Coagulation monitoring kits
          • 3.3.8.1. Insights
          • 3.3.8.2. Key Takeaways
        • 3.3.9. Cardiometabolic monitoring kits
          • 3.3.9.1. Insights
          • 3.3.9.2. Key Takeaways
        • 3.3.10. Others
          • 3.3.10.1. Insights
          • 3.3.10.2. Key Takeaways
      • 3.4. Global Near-Patient Molecular Solutions Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Technology, 2020-2034
      • 3.5. Global Near-Patient Molecular Solutions Market Attractiveness Analysis, By Technology
        • 3.5.1. PCR-based
          • 3.5.1.1. Insights
          • 3.5.1.2. Key Takeaways
        • 3.5.2. Microarray-based
          • 3.5.2.1. Insights
          • 3.5.2.2. Key Takeaways
        • 3.5.3. Hybridization-based
          • 3.5.3.1. Insights
          • 3.5.3.2. Key Takeaways
        • 3.5.4. Genetic sequencing-based
          • 3.5.4.1. Insights
          • 3.5.4.2. Key Takeaways
      • 3.6. Global Near-Patient Molecular Solutions Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-user, 2020-2034
      • 3.7. Global Near-Patient Molecular Solutions Market Attractiveness Analysis, By End-user
        • 3.7.1. Hospitals
          • 3.7.1.1. Insights
          • 3.7.1.2. Key Takeaways
        • 3.7.2. Research laboratories
          • 3.7.2.1. Insights
          • 3.7.2.2. Key Takeaways
        • 3.7.3. Homecare
          • 3.7.3.1. Insights
          • 3.7.3.2. Key Takeaways
        • 3.7.4. Diagnostic laboratories
          • 3.7.4.1. Insights
          • 3.7.4.2. Key Takeaways
    • 4. Global Near-Patient Molecular Solutions Market Analysis and Forecast, By Region, 2020-2034
      • 4.1. Key Findings
      • 4.2. Global Near-Patient Molecular Solutions Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Region, 2020-2034
        • 4.2.1. North America
          • 4.2.1.1. Regional Insights
        • 4.2.2. Europe
          • 4.2.2.1. Regional Insights
        • 4.2.3. Asia Pacific
          • 4.2.3.1. Regional Insights
        • 4.2.4. Latin America
          • 4.2.4.1. Regional Insights
        • 4.2.5. Middle East & Africa
          • 4.2.5.1. Regional Insights
      • 4.3. Global Near-Patient Molecular Solutions Market Attractiveness Analysis, By Region
    • 5. North America Near-Patient Molecular Solutions Market Analysis and Forecast, 2020-2034
      • 5.1. Key Findings
      • 5.2. North America Near-Patient Molecular Solutions Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product Type, 2020-2034
      • 5.3. North America Near-Patient Molecular Solutions Market Attractiveness Analysis, By Product Type
      • 5.4. North America Near-Patient Molecular Solutions Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Technology, 2020-2034
      • 5.5. North America Near-Patient Molecular Solutions Market Attractiveness Analysis, By Technology
      • 5.6. North America Near-Patient Molecular Solutions Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-user, 2020-2034
      • 5.7. North America Near-Patient Molecular Solutions Market Attractiveness Analysis, By End-user
      • 5.8. North America Near-Patient Molecular Solutions Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
      • 5.9. North America Near-Patient Molecular Solutions Market Attractiveness Analysis, By Country
        • 5.9.1. The US
        • 5.9.2. Canada
    • 6. Europe Near-Patient Molecular Solutions Market Analysis and Forecast, 2020-2034
      • 6.1. Key Findings
      • 6.2. Europe Near-Patient Molecular Solutions Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product Type, 2020-2034
      • 6.3. Europe Near-Patient Molecular Solutions Market Attractiveness Analysis, By Product Type
      • 6.4. Europe Near-Patient Molecular Solutions Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Technology, 2020-2034
      • 6.5. Europe Near-Patient Molecular Solutions Market Attractiveness Analysis, By Technology
      • 6.6. Europe Near-Patient Molecular Solutions Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-user, 2020-2034
      • 6.7. Europe Near-Patient Molecular Solutions Market Attractiveness Analysis, By End-user
      • 6.8. Europe Near-Patient Molecular Solutions Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
      • 6.9. Europe Near-Patient Molecular Solutions Market Attractiveness Analysis, By Country
        • 6.9.1. Germany
        • 6.9.2. The UK
        • 6.9.3. France
        • 6.9.4. Spain
        • 6.9.5. Italy
        • 6.9.6. Russia
        • 6.9.7. Netherland
        • 6.9.8. Rest of Europe
    • 7. Asia Pacific Near-Patient Molecular Solutions Market Analysis and Forecast, 2020-2034
      • 7.1. Key Findings
      • 7.2. Asia Pacific Near-Patient Molecular Solutions Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product Type, 2020-2034
      • 7.3. Asia Pacific Near-Patient Molecular Solutions Market Attractiveness Analysis, By Product Type
      • 7.4. Asia Pacific Near-Patient Molecular Solutions Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Technology, 2020-2034
      • 7.5. Asia Pacific Near-Patient Molecular Solutions Market Attractiveness Analysis, By Technology
      • 7.6. Asia Pacific Near-Patient Molecular Solutions Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-user, 2020-2034
      • 7.7. Asia Pacific Near-Patient Molecular Solutions Market Attractiveness Analysis, By End-user
      • 7.8. Asia Pacific Near-Patient Molecular Solutions Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
      • 7.9. Asia Pacific Near-Patient Molecular Solutions Market Attractiveness Analysis, By Country
        • 7.9.1. China
        • 7.9.2. Japan
        • 7.9.3. South Korea
        • 7.9.4. India
        • 7.9.5. Australia
        • 7.9.6. New Zealand
        • 7.9.7. Singapore
        • 7.9.8. Thailand
        • 7.9.9. Vietnam
        • 7.9.10. Rest of Asia Pacific
    • 8. Latin America Near-Patient Molecular Solutions Market Analysis and Forecast, 2020-2034
      • 8.1. Key Findings
      • 8.2. Latin America Near-Patient Molecular Solutions Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product Type, 2020-2034
      • 8.3. Latin America Near-Patient Molecular Solutions Market Attractiveness Analysis, By Product Type
      • 8.4. Latin America Near-Patient Molecular Solutions Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Technology, 2020-2034
      • 8.5. Latin America Near-Patient Molecular Solutions Market Attractiveness Analysis, By Technology
      • 8.6. Latin America Near-Patient Molecular Solutions Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-user, 2020-2034
      • 8.7. Latin America Near-Patient Molecular Solutions Market Attractiveness Analysis, By End-user
      • 8.8. Latin America Near-Patient Molecular Solutions Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
      • 8.9. Latin America Near-Patient Molecular Solutions Market Attractiveness Analysis, By Country
        • 8.9.1. Brazil
        • 8.9.2. Mexico
        • 8.9.3. Rest of Latin America
    • 9. Middle East & Africa Near-Patient Molecular Solutions Market Analysis and Forecast, 2020-2034
      • 9.1. Key Findings
      • 9.2. Middle East & Africa Near-Patient Molecular Solutions Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product Type, 2020-2034
      • 9.3. Middle East & Africa Near-Patient Molecular Solutions Market Attractiveness Analysis, By Product Type
      • 9.4. Middle East & Africa Near-Patient Molecular Solutions Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Technology, 2020-2034
      • 9.5. Middle East & Africa Near-Patient Molecular Solutions Market Attractiveness Analysis, By Technology
      • 9.6. Middle East & Africa Near-Patient Molecular Solutions Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-user, 2020-2034
      • 9.7. Middle East & Africa Near-Patient Molecular Solutions Market Attractiveness Analysis, By End-user
      • 9.8. Middle East & Africa Near-Patient Molecular Solutions Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
      • 9.9. Middle East & Africa Near-Patient Molecular Solutions Market Attractiveness Analysis, By Country
        • 9.9.1. South Africa
        • 9.9.2. Saudi Arabia
        • 9.9.3. UAE
        • 9.9.4. Rest of Middle East & Africa
    • 10. Competitive Landscape & Company Profiles
      • 10.1. Market Competition Scenario Analysis, By Company
        • 10.1.1. Key Takeaways
      • 10.2. Overview of Major Market Players
      • 10.3. Competitor Landscape
      • 10.4. Strategic Mapping
      • 10.5. Company Life Cycle Analysis
      • 10.6. Company Market Share Analysis
      • 10.7. Company Profiles
        • 10.7.1. Thermo Fisher Scientific
          • 10.7.1.1. Company Details
          • 10.7.1.2. Business Overview
          • 10.7.1.3. Product Portfolio
          • 10.7.1.4. Financial Insights
          • 10.7.1.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.1.6. SWOT Analysis
          • 10.7.1.7. Geographic Footprint
        • 10.7.2. Siemens Healthineers
          • 10.7.2.1. Company Details
          • 10.7.2.2. Business Overview
          • 10.7.2.3. Product Portfolio
          • 10.7.2.4. Financial Insights
          • 10.7.2.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.2.6. SWOT Analysis
          • 10.7.2.7. Geographic Footprint
        • 10.7.3. Roche Diagnostics
          • 10.7.3.1. Company Details
          • 10.7.3.2. Business Overview
          • 10.7.3.3. Product Portfolio
          • 10.7.3.4. Financial Insights
          • 10.7.3.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.3.6. SWOT Analysis
          • 10.7.3.7. Geographic Footprint
        • 10.7.4. QIAGEN N.V.
          • 10.7.4.1. Company Details
          • 10.7.4.2. Business Overview
          • 10.7.4.3. Product Portfolio
          • 10.7.4.4. Financial Insights
          • 10.7.4.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.4.6. SWOT Analysis
          • 10.7.4.7. Geographic Footprint
        • 10.7.5. PerkinElmer
          • 10.7.5.1. Company Details
          • 10.7.5.2. Business Overview
          • 10.7.5.3. Product Portfolio
          • 10.7.5.4. Financial Insights
          • 10.7.5.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.5.6. SWOT Analysis
          • 10.7.5.7. Geographic Footprint
        • 10.7.6. Illumina, Inc.
          • 10.7.6.1. Company Details
          • 10.7.6.2. Business Overview
          • 10.7.6.3. Product Portfolio
          • 10.7.6.4. Financial Insights
          • 10.7.6.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.6.6. SWOT Analysis
          • 10.7.6.7. Geographic Footprint
        • 10.7.7. Cepheid (a Danaher company)
          • 10.7.7.1. Company Details
          • 10.7.7.2. Business Overview
          • 10.7.7.3. Product Portfolio
          • 10.7.7.4. Financial Insights
          • 10.7.7.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.7.6. SWOT Analysis
          • 10.7.7.7. Geographic Footprint
        • 10.7.8. Bio-Rad Laboratories
          • 10.7.8.1. Company Details
          • 10.7.8.2. Business Overview
          • 10.7.8.3. Product Portfolio
          • 10.7.8.4. Financial Insights
          • 10.7.8.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.8.6. SWOT Analysis
          • 10.7.8.7. Geographic Footprint
        • 10.7.9. Becton, Dickinson and Company (BD)
          • 10.7.9.1. Company Details
          • 10.7.9.2. Business Overview
          • 10.7.9.3. Product Portfolio
          • 10.7.9.4. Financial Insights
          • 10.7.9.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.9.6. SWOT Analysis
          • 10.7.9.7. Geographic Footprint
        • 10.7.10. Abbott Laboratories
          • 10.7.10.1. Company Details
          • 10.7.10.2. Business Overview
          • 10.7.10.3. Product Portfolio
          • 10.7.10.4. Financial Insights
          • 10.7.10.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.10.6. SWOT Analysis
          • 10.7.10.7. Geographic Footprint
    • 11. Methodology and Data Source
      • 11.1. Methodology/Research Approach
      • 11.2. Market Size Estimation
      • 11.3. Market Breakdown and Data Triangulation
      • 11.4. Data Source
      • 11.5. Secondary Sources
      • 11.6. Primary Sources
      • 11.7. Appendix
      • 11.8. Disclaimer
    • List of Tables
      • Table 1. Global Near-Patient Molecular Solutions Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 2. Global Near-Patient Molecular Solutions Market Value (US$ Mn), By Technology, 2020-2034
      • Table 3. Global Near-Patient Molecular Solutions Market Value (US$ Mn), By End-user, 2020-2034
      • Table 4. Global Near-Patient Molecular Solutions Market Value (US$ Mn), By Region, 2020-2034
      • Table 5. North America Near-Patient Molecular Solutions Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 6. North America Near-Patient Molecular Solutions Market Value (US$ Mn), By Technology, 2020-2034
      • Table 7. North America Near-Patient Molecular Solutions Market Value (US$ Mn), By End-user, 2020-2034
      • Table 8. North America Near-Patient Molecular Solutions Market Value (US$ Mn), By Country, 2020-2034
      • Table 9. The US Near-Patient Molecular Solutions Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 10. The US Near-Patient Molecular Solutions Market Value (US$ Mn), By Technology, 2020-2034
      • Table 11. The US Near-Patient Molecular Solutions Market Value (US$ Mn), By End-user, 2020-2034
      • Table 12. Canada Near-Patient Molecular Solutions Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 13. Canada Near-Patient Molecular Solutions Market Value (US$ Mn), By Technology, 2020-2034
      • Table 14. Canada Near-Patient Molecular Solutions Market Value (US$ Mn), By End-user, 2020-2034
      • Table 15. Europe Near-Patient Molecular Solutions Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 16. Europe Near-Patient Molecular Solutions Market Value (US$ Mn), By Technology, 2020-2034
      • Table 17. Europe Near-Patient Molecular Solutions Market Value (US$ Mn), By End-user, 2020-2034
      • Table 18. Europe Near-Patient Molecular Solutions Market Value (US$ Mn), By Country, 2020-2034
      • Table 19. Germany Near-Patient Molecular Solutions Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 20. Germany Near-Patient Molecular Solutions Market Value (US$ Mn), By Technology, 2020-2034
      • Table 21. Germany Near-Patient Molecular Solutions Market Value (US$ Mn), By End-user, 2020-2034
      • Table 22. The UK Near-Patient Molecular Solutions Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 23. The UK Near-Patient Molecular Solutions Market Value (US$ Mn), By Technology, 2020-2034
      • Table 24. The UK Near-Patient Molecular Solutions Market Value (US$ Mn), By End-user, 2020-2034
      • Table 25. France Near-Patient Molecular Solutions Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 26. France Near-Patient Molecular Solutions Market Value (US$ Mn), By Technology, 2020-2034
      • Table 27. France Near-Patient Molecular Solutions Market Value (US$ Mn), By End-user, 2020-2034
      • Table 28. Spain Near-Patient Molecular Solutions Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 29. Spain Near-Patient Molecular Solutions Market Value (US$ Mn), By Technology, 2020-2034
      • Table 30. Spain Near-Patient Molecular Solutions Market Value (US$ Mn), By End-user, 2020-2034
      • Table 31. Italy Near-Patient Molecular Solutions Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 32. Italy Near-Patient Molecular Solutions Market Value (US$ Mn), By Technology, 2020-2034
      • Table 33. Italy Near-Patient Molecular Solutions Market Value (US$ Mn), By End-user, 2020-2034
      • Table 34. Russia Near-Patient Molecular Solutions Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 35. Russia Near-Patient Molecular Solutions Market Value (US$ Mn), By Technology, 2020-2034
      • Table 36. Russia Near-Patient Molecular Solutions Market Value (US$ Mn), By End-user, 2020-2034
      • Table 37. Netherland Near-Patient Molecular Solutions Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 38. Netherland Near-Patient Molecular Solutions Market Value (US$ Mn), By Technology, 2020-2034
      • Table 39. Netherland Near-Patient Molecular Solutions Market Value (US$ Mn), By End-user, 2020-2034
      • Table 40. Rest of Europe Near-Patient Molecular Solutions Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 41. Rest of Europe Near-Patient Molecular Solutions Market Value (US$ Mn), By Technology, 2020-2034
      • Table 42. Rest of Europe Near-Patient Molecular Solutions Market Value (US$ Mn), By End-user, 2020-2034
      • Table 43. Asia Pacific Near-Patient Molecular Solutions Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 44. Asia Pacific Near-Patient Molecular Solutions Market Value (US$ Mn), By Technology, 2020-2034
      • Table 45. Asia Pacific Near-Patient Molecular Solutions Market Value (US$ Mn), By End-user, 2020-2034
      • Table 46. Asia Pacific Near-Patient Molecular Solutions Market Value (US$ Mn), By Country, 2020-2034
      • Table 47. China Near-Patient Molecular Solutions Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 48. China Near-Patient Molecular Solutions Market Value (US$ Mn), By Technology, 2020-2034
      • Table 49. China Near-Patient Molecular Solutions Market Value (US$ Mn), By End-user, 2020-2034
      • Table 50. India Near-Patient Molecular Solutions Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 51. India Near-Patient Molecular Solutions Market Value (US$ Mn), By Technology, 2020-2034
      • Table 52. India Near-Patient Molecular Solutions Market Value (US$ Mn), By End-user, 2020-2034
      • Table 53. Japan Near-Patient Molecular Solutions Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 54. Japan Near-Patient Molecular Solutions Market Value (US$ Mn), By Technology, 2020-2034
      • Table 55. Japan Near-Patient Molecular Solutions Market Value (US$ Mn), By End-user, 2020-2034
      • Table 56. South Korea Near-Patient Molecular Solutions Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 57. South Korea Near-Patient Molecular Solutions Market Value (US$ Mn), By Technology, 2020-2034
      • Table 58. South Korea Near-Patient Molecular Solutions Market Value (US$ Mn), By End-user, 2020-2034
      • Table 59. Australia Near-Patient Molecular Solutions Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 60. Australia Near-Patient Molecular Solutions Market Value (US$ Mn), By Technology, 2020-2034
      • Table 61. Australia Near-Patient Molecular Solutions Market Value (US$ Mn), By End-user, 2020-2034
      • Table 62. New Zealand Near-Patient Molecular Solutions Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 63. New Zealand Near-Patient Molecular Solutions Market Value (US$ Mn), By Technology, 2020-2034
      • Table 64. New Zealand Near-Patient Molecular Solutions Market Value (US$ Mn), By End-user, 2020-2034
      • Table 65. Singapore Near-Patient Molecular Solutions Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 66. Singapore Near-Patient Molecular Solutions Market Value (US$ Mn), By Technology, 2020-2034
      • Table 67. Singapore Near-Patient Molecular Solutions Market Value (US$ Mn), By End-user, 2020-2034
      • Table 68. Thailand Near-Patient Molecular Solutions Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 69. Thailand Near-Patient Molecular Solutions Market Value (US$ Mn), By Technology, 2020-2034
      • Table 70. Thailand Near-Patient Molecular Solutions Market Value (US$ Mn), By End-user, 2020-2034
      • Table 71. Vietnam Near-Patient Molecular Solutions Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 72. Vietnam Near-Patient Molecular Solutions Market Value (US$ Mn), By Technology, 2020-2034
      • Table 73. Vietnam Near-Patient Molecular Solutions Market Value (US$ Mn), By End-user, 2020-2034
      • Table 74. Rest of Asia Pacific Near-Patient Molecular Solutions Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 75. Rest of Asia Pacific Near-Patient Molecular Solutions Market Value (US$ Mn), By Technology, 2020-2034
      • Table 76. Rest of Asia Pacific Near-Patient Molecular Solutions Market Value (US$ Mn), By End-user, 2020-2034
      • Table 77. Latin America Near-Patient Molecular Solutions Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 78. Latin America Near-Patient Molecular Solutions Market Value (US$ Mn), By Technology, 2020-2034
      • Table 79. Latin America Near-Patient Molecular Solutions Market Value (US$ Mn), By End-user, 2020-2034
      • Table 80. Latin America Near-Patient Molecular Solutions Market Value (US$ Mn), By Country, 2020-2034
      • Table 81. Brazil Near-Patient Molecular Solutions Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 82. Brazil Near-Patient Molecular Solutions Market Value (US$ Mn), By Technology, 2020-2034
      • Table 83. Brazil Near-Patient Molecular Solutions Market Value (US$ Mn), By End-user, 2020-2034
      • Table 84. Mexico Near-Patient Molecular Solutions Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 85. Mexico Near-Patient Molecular Solutions Market Value (US$ Mn), By Technology, 2020-2034
      • Table 86. Mexico Near-Patient Molecular Solutions Market Value (US$ Mn), By End-user, 2020-2034
      • Table 87. Rest of Latin America Near-Patient Molecular Solutions Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 88. Rest of Latin America Near-Patient Molecular Solutions Market Value (US$ Mn), By Technology, 2020-2034
      • Table 89. Rest of Latin America Near-Patient Molecular Solutions Market Value (US$ Mn), By End-user, 2020-2034
      • Table 90. Middle East & Africa Near-Patient Molecular Solutions Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 91. Middle East & Africa Near-Patient Molecular Solutions Market Value (US$ Mn), By Technology, 2020-2034
      • Table 92. Middle East & Africa Near-Patient Molecular Solutions Market Value (US$ Mn), By End-user, 2020-2034
      • Table 93. Middle East & Africa Near-Patient Molecular Solutions Market Value (US$ Mn), By Country, 2020-2034
      • Table 94. South Africa Near-Patient Molecular Solutions Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 95. South Africa Near-Patient Molecular Solutions Market Value (US$ Mn), By Technology, 2020-2034
      • Table 96. South Africa Near-Patient Molecular Solutions Market Value (US$ Mn), By End-user, 2020-2034
      • Table 97. Saudi Arabia Near-Patient Molecular Solutions Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 98. Saudi Arabia Near-Patient Molecular Solutions Market Value (US$ Mn), By Technology, 2020-2034
      • Table 99. Saudi Arabia Near-Patient Molecular Solutions Market Value (US$ Mn), By End-user, 2020-2034
      • Table 100. UAE Near-Patient Molecular Solutions Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 101. UAE Near-Patient Molecular Solutions Market Value (US$ Mn), By Technology, 2020-2034
      • Table 102. UAE Near-Patient Molecular Solutions Market Value (US$ Mn), By End-user, 2020-2034
      • Table 103. Rest of Middle East & Africa Near-Patient Molecular Solutions Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 104. Rest of Middle East & Africa Near-Patient Molecular Solutions Market Value (US$ Mn), By Technology, 2020-2034
      • Table 105. Rest of Middle East & Africa Near-Patient Molecular Solutions Market Value (US$ Mn), By End-user, 2020-2034
    • List of Figures
      • Figure 1. Global Near-Patient Molecular Solutions Market Snapshot: Market Value (US$ Mn), 2020-2034
      • Figure 2. Opportunity Map
      • Figure 3. Opportunity Orbit
      • Figure 4. Regional Market Share and BPS Analysis in Near-Patient Molecular Solutions Market
      • Figure 5. Global Near-Patient Molecular Solutions Market Analysis, By Product Type, 2020, 2024 and 2034
      • Figure 6. Global Near-Patient Molecular Solutions Market Attractiveness Analysis, By Product Type
      • Figure 7. Global Near-Patient Molecular Solutions Market Analysis, By Technology, 2020, 2024 and 2034
      • Figure 8. Global Near-Patient Molecular Solutions Market Attractiveness Analysis, By Technology
      • Figure 9. Global Near-Patient Molecular Solutions Market Analysis, By End-user, 2020, 2024 and 2034
      • Figure 10. Global Near-Patient Molecular Solutions Market Attractiveness Analysis, By End-user
      • Figure 11. Global Near-Patient Molecular Solutions Market Analysis, By Region, 2020, 2024 and 2034
      • Figure 12. Global Near-Patient Molecular Solutions Market Attractiveness Analysis, By Region
      • Figure 13. North America Near-Patient Molecular Solutions Market Analysis, By Product Type, 2020, 2024 and 2034
      • Figure 14. North America Near-Patient Molecular Solutions Market Attractiveness Analysis, By Product Type
      • Figure 15. North America Near-Patient Molecular Solutions Market (US$ Mn), by Infectious diseases testing kits, 2020-2034
      • Figure 16. North America Near-Patient Molecular Solutions Market (US$ Mn), by Urinalysis testing kits, 2020-2034
      • Figure 17. North America Near-Patient Molecular Solutions Market (US$ Mn), by Tumor/cancer markers, 2020-2034
      • Figure 18. North America Near-Patient Molecular Solutions Market (US$ Mn), by Pregnancy and fertility, 2020-2034
      • Figure 19. North America Near-Patient Molecular Solutions Market (US$ Mn), by Hematology testing kits, 2020-2034
      • Figure 20. North America Near-Patient Molecular Solutions Market (US$ Mn), by Glucose monitoring kits, 2020-2034
      • Figure 21. North America Near-Patient Molecular Solutions Market (US$ Mn), by Drugs-of-abuse testing kits, 2020-2034
      • Figure 22. North America Near-Patient Molecular Solutions Market (US$ Mn), by Coagulation monitoring kits, 2020-2034
      • Figure 23. North America Near-Patient Molecular Solutions Market (US$ Mn), by Cardiometabolic monitoring kits, 2020-2034
      • Figure 24. North America Near-Patient Molecular Solutions Market (US$ Mn), by Others, 2020-2034
      • Figure 25. North America Near-Patient Molecular Solutions Market Analysis, By Technology, 2020, 2024 and 2034
      • Figure 26. North America Near-Patient Molecular Solutions Market Attractiveness Analysis, By Technology
      • Figure 27. North America Near-Patient Molecular Solutions Market (US$ Mn), by PCR-based, 2020-2034
      • Figure 28. North America Near-Patient Molecular Solutions Market (US$ Mn), by Microarray-based, 2020-2034
      • Figure 29. North America Near-Patient Molecular Solutions Market (US$ Mn), by Hybridization-based, 2020-2034
      • Figure 30. North America Near-Patient Molecular Solutions Market (US$ Mn), by Genetic sequencing-based, 2020-2034
      • Figure 31. North America Near-Patient Molecular Solutions Market Analysis, By End-user, 2020, 2024 and 2034
      • Figure 32. North America Near-Patient Molecular Solutions Market Attractiveness Analysis, By End-user
      • Figure 33. North America Near-Patient Molecular Solutions Market (US$ Mn), by Hospitals, 2020-2034
      • Figure 34. North America Near-Patient Molecular Solutions Market (US$ Mn), by Research laboratories, 2020-2034
      • Figure 35. North America Near-Patient Molecular Solutions Market (US$ Mn), by Homecare, 2020-2034
      • Figure 36. North America Near-Patient Molecular Solutions Market (US$ Mn), by Diagnostic laboratories, 2020-2034
      • Figure 37. North America Near-Patient Molecular Solutions Market Analysis, By Country, 2020, 2024 and 2034
      • Figure 38. North America Near-Patient Molecular Solutions Market Attractiveness Analysis, By Country
      • Figure 39. Europe Near-Patient Molecular Solutions Market Analysis, By Product Type, 2020, 2024 and 2034
      • Figure 40. Europe Near-Patient Molecular Solutions Market Attractiveness Analysis, By Product Type
      • Figure 41. Europe Near-Patient Molecular Solutions Market (US$ Mn), by Infectious diseases testing kits, 2020-2034
      • Figure 42. Europe Near-Patient Molecular Solutions Market (US$ Mn), by Urinalysis testing kits, 2020-2034
      • Figure 43. Europe Near-Patient Molecular Solutions Market (US$ Mn), by Tumor/cancer markers, 2020-2034
      • Figure 44. Europe Near-Patient Molecular Solutions Market (US$ Mn), by Pregnancy and fertility, 2020-2034
      • Figure 45. Europe Near-Patient Molecular Solutions Market (US$ Mn), by Hematology testing kits, 2020-2034
      • Figure 46. Europe Near-Patient Molecular Solutions Market (US$ Mn), by Glucose monitoring kits, 2020-2034
      • Figure 47. Europe Near-Patient Molecular Solutions Market (US$ Mn), by Drugs-of-abuse testing kits, 2020-2034
      • Figure 48. Europe Near-Patient Molecular Solutions Market (US$ Mn), by Coagulation monitoring kits, 2020-2034
      • Figure 49. Europe Near-Patient Molecular Solutions Market (US$ Mn), by Cardiometabolic monitoring kits, 2020-2034
      • Figure 50. Europe Near-Patient Molecular Solutions Market (US$ Mn), by Others, 2020-2034
      • Figure 51. Europe Near-Patient Molecular Solutions Market Analysis, By Technology, 2020, 2024 and 2034
      • Figure 52. Europe Near-Patient Molecular Solutions Market Attractiveness Analysis, By Technology
      • Figure 53. Europe Near-Patient Molecular Solutions Market (US$ Mn), by PCR-based, 2020-2034
      • Figure 54. Europe Near-Patient Molecular Solutions Market (US$ Mn), by Microarray-based, 2020-2034
      • Figure 55. Europe Near-Patient Molecular Solutions Market (US$ Mn), by Hybridization-based, 2020-2034
      • Figure 56. Europe Near-Patient Molecular Solutions Market (US$ Mn), by Genetic sequencing-based, 2020-2034
      • Figure 57. Europe Near-Patient Molecular Solutions Market Analysis, By End-user, 2020, 2024 and 2034
      • Figure 58. Europe Near-Patient Molecular Solutions Market Attractiveness Analysis, By End-user
      • Figure 59. Europe Near-Patient Molecular Solutions Market (US$ Mn), by Hospitals, 2020-2034
      • Figure 60. Europe Near-Patient Molecular Solutions Market (US$ Mn), by Research laboratories, 2020-2034
      • Figure 61. Europe Near-Patient Molecular Solutions Market (US$ Mn), by Homecare, 2020-2034
      • Figure 62. Europe Near-Patient Molecular Solutions Market (US$ Mn), by Diagnostic laboratories, 2020-2034
      • Figure 63. Europe Near-Patient Molecular Solutions Market Analysis, By Country, 2020, 2024 and 2034
      • Figure 64. Europe Near-Patient Molecular Solutions Market Attractiveness Analysis, By Country
      • Figure 65. Asia Pacific Near-Patient Molecular Solutions Market Analysis, By Product Type, 2020, 2024 and 2034
      • Figure 66. Asia Pacific Near-Patient Molecular Solutions Market Attractiveness Analysis, By Product Type
      • Figure 67. Asia Pacific Near-Patient Molecular Solutions Market (US$ Mn), by Infectious diseases testing kits, 2020-2034
      • Figure 68. Asia Pacific Near-Patient Molecular Solutions Market (US$ Mn), by Urinalysis testing kits, 2020-2034
      • Figure 69. Asia Pacific Near-Patient Molecular Solutions Market (US$ Mn), by Tumor/cancer markers, 2020-2034
      • Figure 70. Asia Pacific Near-Patient Molecular Solutions Market (US$ Mn), by Pregnancy and fertility, 2020-2034
      • Figure 71. Asia Pacific Near-Patient Molecular Solutions Market (US$ Mn), by Hematology testing kits, 2020-2034
      • Figure 72. Asia Pacific Near-Patient Molecular Solutions Market (US$ Mn), by Glucose monitoring kits, 2020-2034
      • Figure 73. Asia Pacific Near-Patient Molecular Solutions Market (US$ Mn), by Drugs-of-abuse testing kits, 2020-2034
      • Figure 74. Asia Pacific Near-Patient Molecular Solutions Market (US$ Mn), by Coagulation monitoring kits, 2020-2034
      • Figure 75. Asia Pacific Near-Patient Molecular Solutions Market (US$ Mn), by Cardiometabolic monitoring kits, 2020-2034
      • Figure 76. Asia Pacific Near-Patient Molecular Solutions Market (US$ Mn), by Others, 2020-2034
      • Figure 77. Asia Pacific Near-Patient Molecular Solutions Market Analysis, By Technology, 2020, 2024 and 2034
      • Figure 78. Asia Pacific Near-Patient Molecular Solutions Market Attractiveness Analysis, By Technology
      • Figure 79. Asia Pacific Near-Patient Molecular Solutions Market (US$ Mn), by PCR-based, 2020-2034
      • Figure 80. Asia Pacific Near-Patient Molecular Solutions Market (US$ Mn), by Microarray-based, 2020-2034
      • Figure 81. Asia Pacific Near-Patient Molecular Solutions Market (US$ Mn), by Hybridization-based, 2020-2034
      • Figure 82. Asia Pacific Near-Patient Molecular Solutions Market (US$ Mn), by Genetic sequencing-based, 2020-2034
      • Figure 83. Asia Pacific Near-Patient Molecular Solutions Market Analysis, By End-user, 2020, 2024 and 2034
      • Figure 84. Asia Pacific Near-Patient Molecular Solutions Market Attractiveness Analysis, By End-user
      • Figure 85. Asia Pacific Near-Patient Molecular Solutions Market (US$ Mn), by Hospitals, 2020-2034
      • Figure 86. Asia Pacific Near-Patient Molecular Solutions Market (US$ Mn), by Research laboratories, 2020-2034
      • Figure 87. Asia Pacific Near-Patient Molecular Solutions Market (US$ Mn), by Homecare, 2020-2034
      • Figure 88. Asia Pacific Near-Patient Molecular Solutions Market (US$ Mn), by Diagnostic laboratories, 2020-2034
      • Figure 89. Asia Pacific Near-Patient Molecular Solutions Market Analysis, By Country, 2020, 2024 and 2034
      • Figure 90. Asia Pacific Near-Patient Molecular Solutions Market Attractiveness Analysis, By Country
      • Figure 91. Latin America Near-Patient Molecular Solutions Market Analysis, By Product Type, 2020, 2024 and 2034
      • Figure 92. Latin America Near-Patient Molecular Solutions Market Attractiveness Analysis, By Product Type
      • Figure 93. Latin America Near-Patient Molecular Solutions Market (US$ Mn), by Infectious diseases testing kits, 2020-2034
      • Figure 94. Latin America Near-Patient Molecular Solutions Market (US$ Mn), by Urinalysis testing kits, 2020-2034
      • Figure 95. Latin America Near-Patient Molecular Solutions Market (US$ Mn), by Tumor/cancer markers, 2020-2034
      • Figure 96. Latin America Near-Patient Molecular Solutions Market (US$ Mn), by Pregnancy and fertility, 2020-2034
      • Figure 97. Latin America Near-Patient Molecular Solutions Market (US$ Mn), by Hematology testing kits, 2020-2034
      • Figure 98. Latin America Near-Patient Molecular Solutions Market (US$ Mn), by Glucose monitoring kits, 2020-2034
      • Figure 99. Latin America Near-Patient Molecular Solutions Market (US$ Mn), by Drugs-of-abuse testing kits, 2020-2034
      • Figure 100. Latin America Near-Patient Molecular Solutions Market (US$ Mn), by Coagulation monitoring kits, 2020-2034
      • Figure 101. Latin America Near-Patient Molecular Solutions Market (US$ Mn), by Cardiometabolic monitoring kits, 2020-2034
      • Figure 102. Latin America Near-Patient Molecular Solutions Market (US$ Mn), by Others, 2020-2034
      • Figure 103. Latin America Near-Patient Molecular Solutions Market Analysis, By Technology, 2020, 2024 and 2034
      • Figure 104. Latin America Near-Patient Molecular Solutions Market Attractiveness Analysis, By Technology
      • Figure 105. Latin America Near-Patient Molecular Solutions Market (US$ Mn), by PCR-based, 2020-2034
      • Figure 106. Latin America Near-Patient Molecular Solutions Market (US$ Mn), by Microarray-based, 2020-2034
      • Figure 107. Latin America Near-Patient Molecular Solutions Market (US$ Mn), by Hybridization-based, 2020-2034
      • Figure 108. Latin America Near-Patient Molecular Solutions Market (US$ Mn), by Genetic sequencing-based, 2020-2034
      • Figure 109. Latin America Near-Patient Molecular Solutions Market Analysis, By End-user, 2020, 2024 and 2034
      • Figure 110. Latin America Near-Patient Molecular Solutions Market Attractiveness Analysis, By End-user
      • Figure 111. Latin America Near-Patient Molecular Solutions Market (US$ Mn), by Hospitals, 2020-2034
      • Figure 112. Latin America Near-Patient Molecular Solutions Market (US$ Mn), by Research laboratories, 2020-2034
      • Figure 113. Latin America Near-Patient Molecular Solutions Market (US$ Mn), by Homecare, 2020-2034
      • Figure 114. Latin America Near-Patient Molecular Solutions Market (US$ Mn), by Diagnostic laboratories, 2020-2034
      • Figure 115. Latin America Near-Patient Molecular Solutions Market Analysis, By Country, 2020, 2024 and 2034
      • Figure 116. Latin America Near-Patient Molecular Solutions Market Attractiveness Analysis, By Country
      • Figure 117. Middle East & Africa Near-Patient Molecular Solutions Market Analysis, By Product Type, 2020, 2024 and 2034
      • Figure 118. Middle East & Africa Near-Patient Molecular Solutions Market Attractiveness Analysis, By Product Type
      • Figure 119. Middle East & Africa Near-Patient Molecular Solutions Market (US$ Mn), by Infectious diseases testing kits, 2020-2034
      • Figure 120. Middle East & Africa Near-Patient Molecular Solutions Market (US$ Mn), by Urinalysis testing kits, 2020-2034
      • Figure 121. Middle East & Africa Near-Patient Molecular Solutions Market (US$ Mn), by Tumor/cancer markers, 2020-2034
      • Figure 122. Middle East & Africa Near-Patient Molecular Solutions Market (US$ Mn), by Pregnancy and fertility, 2020-2034
      • Figure 123. Middle East & Africa Near-Patient Molecular Solutions Market (US$ Mn), by Hematology testing kits, 2020-2034
      • Figure 124. Middle East & Africa Near-Patient Molecular Solutions Market (US$ Mn), by Glucose monitoring kits, 2020-2034
      • Figure 125. Middle East & Africa Near-Patient Molecular Solutions Market (US$ Mn), by Drugs-of-abuse testing kits, 2020-2034
      • Figure 126. Middle East & Africa Near-Patient Molecular Solutions Market (US$ Mn), by Coagulation monitoring kits, 2020-2034
      • Figure 127. Middle East & Africa Near-Patient Molecular Solutions Market (US$ Mn), by Cardiometabolic monitoring kits, 2020-2034
      • Figure 128. Middle East & Africa Near-Patient Molecular Solutions Market (US$ Mn), by Others, 2020-2034
      • Figure 129. Middle East & Africa Near-Patient Molecular Solutions Market Analysis, By Technology, 2020, 2024 and 2034
      • Figure 130. Middle East & Africa Near-Patient Molecular Solutions Market Attractiveness Analysis, By Technology
      • Figure 131. Middle East & Africa Near-Patient Molecular Solutions Market (US$ Mn), by PCR-based, 2020-2034
      • Figure 132. Middle East & Africa Near-Patient Molecular Solutions Market (US$ Mn), by Microarray-based, 2020-2034
      • Figure 133. Middle East & Africa Near-Patient Molecular Solutions Market (US$ Mn), by Hybridization-based, 2020-2034
      • Figure 134. Middle East & Africa Near-Patient Molecular Solutions Market (US$ Mn), by Genetic sequencing-based, 2020-2034
      • Figure 135. Middle East & Africa Near-Patient Molecular Solutions Market Analysis, By End-user, 2020, 2024 and 2034
      • Figure 136. Middle East & Africa Near-Patient Molecular Solutions Market Attractiveness Analysis, By End-user
      • Figure 137. Middle East & Africa Near-Patient Molecular Solutions Market (US$ Mn), by Hospitals, 2020-2034
      • Figure 138. Middle East & Africa Near-Patient Molecular Solutions Market (US$ Mn), by Research laboratories, 2020-2034
      • Figure 139. Middle East & Africa Near-Patient Molecular Solutions Market (US$ Mn), by Homecare, 2020-2034
      • Figure 140. Middle East & Africa Near-Patient Molecular Solutions Market (US$ Mn), by Diagnostic laboratories, 2020-2034
      • Figure 141. Middle East & Africa Near-Patient Molecular Solutions Market Analysis, By Country, 2020, 2024 and 2034
      • Figure 142. Middle East & Africa Near-Patient Molecular Solutions Market Attractiveness Analysis, By Country

Related Reports

Our Clients

  • Our Clients
Near-Patient Molecular Solutions Market
  • 162285
  • Oct 2025
    • ★★★★★
      ★★★★★
    • (142)
add_shopping_cart Buy Now
Trusted by more than 17382 organizations globally
  • Client Logo
  • Client Logo
  • Client Logo
✖
Request a Sample Report
We'll get back to you as quickly as possible

Find Help
Legal
Explore
Secured Payment Options
Secured Payment Options